摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[3-(6-bromo-2-oxo-2,3-dihydro-1H-indol-4-ylmethyl)-2-oxo-2,3-dihydrobenzoimidazol-1-yl]hexanoic acid methyl ester | 1090903-73-3

中文名称
——
中文别名
——
英文名称
3-[3-(6-bromo-2-oxo-2,3-dihydro-1H-indol-4-ylmethyl)-2-oxo-2,3-dihydrobenzoimidazol-1-yl]hexanoic acid methyl ester
英文别名
3-[3-(6-Bromo-2-oxo-2,3-dihydro-1H-indol-4-ylmethyl)-2-oxo-2,3-dihydro-benzoimidazol-1-yl]-hexanoic acid methyl ester;methyl 3-[3-[(6-bromo-2-oxo-1,3-dihydroindol-4-yl)methyl]-2-oxobenzimidazol-1-yl]hexanoate
3-[3-(6-bromo-2-oxo-2,3-dihydro-1H-indol-4-ylmethyl)-2-oxo-2,3-dihydrobenzoimidazol-1-yl]hexanoic acid methyl ester化学式
CAS
1090903-73-3
化学式
C23H24BrN3O4
mdl
——
分子量
486.365
InChiKey
LVGLHXXYKBXMTK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    31
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    79
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-[3-(6-bromo-2-oxo-2,3-dihydro-1H-indol-4-ylmethyl)-2-oxo-2,3-dihydrobenzoimidazol-1-yl]hexanoic acid methyl ester 在 lithium hydroxide 、 盐酸 作用下, 以 1,4-二氧六环 为溶剂, 反应 1.0h, 以97%的产率得到3-[3-[(6-Bromo-2-oxo-1,3-dihydroindol-4-yl)methyl]-2-oxobenzimidazol-1-yl]hexanoic acid
    参考文献:
    名称:
    Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies
    摘要:
    Chymase plays an important and diverse role in the homeostasis of a number of cardiovascular processes. Herein, we describe the identification of potent, selective chymase inhibitors, developed using fragment-based, structure-guided linking and optimization techniques. High-concentration biophysical screening methods followed by high-throughput crystallography identified an oxindole fragment bound to the S1 pocket of the protein exhibiting a novel interaction pattern hitherto not observed in chymase inhibitors. X-ray crystallographic structures were used to guide the elaboration/linking of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over cathepsin G and that mitigated a number of liabilities associated with poor physicochemical properties of the series it was derived from.
    DOI:
    10.1021/jm400138z
  • 作为产物:
    参考文献:
    名称:
    Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies
    摘要:
    Chymase plays an important and diverse role in the homeostasis of a number of cardiovascular processes. Herein, we describe the identification of potent, selective chymase inhibitors, developed using fragment-based, structure-guided linking and optimization techniques. High-concentration biophysical screening methods followed by high-throughput crystallography identified an oxindole fragment bound to the S1 pocket of the protein exhibiting a novel interaction pattern hitherto not observed in chymase inhibitors. X-ray crystallographic structures were used to guide the elaboration/linking of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over cathepsin G and that mitigated a number of liabilities associated with poor physicochemical properties of the series it was derived from.
    DOI:
    10.1021/jm400138z
点击查看最新优质反应信息

文献信息

  • Benzimidazolone Chymase Inhibitors
    申请人:Abeywardane Asitha
    公开号:US20100240702A1
    公开(公告)日:2010-09-23
    Disclosed are small molecule inhibitors which are useful in treating various diseases and conditions involving chymase.
    公开了一种小分子抑制剂,其在治疗涉及chymase的各种疾病和病况方面是有用的。
  • Benzimidazolone chymase inhibitors
    申请人:Abeywardane Asitha
    公开号:US09150556B2
    公开(公告)日:2015-10-06
    Disclosed are small molecule inhibitors which are useful in treating various diseases and conditions involving chymase.
    本发明揭示了一种小分子抑制剂,可用于治疗涉及痰蛋白酶的各种疾病和病况。
  • BENZIMIDAZOLONE CHYMASE INHIBITORS
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2152674B1
    公开(公告)日:2011-08-03
  • US9150556B2
    申请人:——
    公开号:US9150556B2
    公开(公告)日:2015-10-06
  • [EN] BENZIMIDAZOLONE CHYMASE INHIBITORS<br/>[FR] INHIBITEURS DE BENZIMIDAZOLONE CHYMASE
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2008147697A1
    公开(公告)日:2008-12-04
    [EN] Disclosed are small molecule inhibitors which are useful in treating various diseases and conditions involving chymase.
    [FR] L'invention concerne des inhibiteurs à petites molécules qui sont utiles dans le traitement de diverses maladies et affections impliquant la chymase.
查看更多